Semaglutide Enhances Cognitive Function in American Males with Type 2 Diabetes: 5-Year Study
Reading Time: 2 minutes Introduction Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist primarily used for the management of type 2 diabetes, has garnered attention for its potential effects beyond glycemic control. Recent studies have suggested that semaglutide might influence cognitive function, prompting further research into its neuroprotective properties. This article explores the findings of a longitudinal study conducted over five years, focusing on the impact of semaglutide on cognitive function in American males. Study Design and Methodology The study involved 500 American males aged 45 to 70, all diagnosed with type 2 diabetes. Participants were randomly assigned to receive either semaglutide or a placebo....


